Loading Events
Microscopic Close Up Of The Covid 19 Disease. Coronavirus Illness Spreading In Body Cell. 2019 NCoV Analysis On Microscope Level 3D Rendering
AllianceAvatarArtboard 1 Copy 4

At a Glance

COVID+ Donors: Considerations & Controversies

Tuesday, November 16, 2021, at 2:00pm – 3:00pm EST

Continuing Education Credits

No CE Credits Awarded

COVID+ Donors: Considerations & Controversies

Tuesday, November 16, 2021, at 2:00pm – 3:00pm EST / 11:00am – 12:00pm PST

Purpose / Goal

The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.

Sessions are designed to be approximately 30-45 minutes in length and encourage real-time feedback and participation from viewers.

Overview: In this session, we will discuss the risks for transmission of COVID to recipients of organs from donors with a history of or active COVID which are not fully understood. The goals are to discuss under what specific conditions might it be appropriate to use organs from COVID+ donors, and to describe the potential benefits vs risks.

Learning Objectives
  • Summarize data on use of donors with positive SARS-CoV test results.
  • Describe current guidelines regarding the use of COVID+ donors.
  • List potential risks for use of organs from COVID+ donors.


Ajit Limaye
Ajit Limaye
Professor of Medicine & Laboratory Medicine, Director, Solid-Organ Transplant Infectious Disease Program, Department of Medicine
UW Medicine


Who Does This Benefit?

Transplant Center Professionals, Surgeons, Organ Procurement Organization Professionals, Quality Improvement Professionals and Leadership, OPO and Transplant Center Leadership, Directors, Managers, Clinicians, Front-line staff and individuals interested in improving relationships between OPO and Transplant programs